These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28360692)

  • 1. Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL).
    Dereli EE; Yaliman A; Kuru Çolaka T; Çakmak A; Razak Özdinçler A; Badilli Demirbaş Ş
    Noro Psikiyatr Ars; 2015 Jun; 52(2):128-132. PubMed ID: 28360692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV).
    Serrano-Dueñas M; Martínez-Martín P; Vaca-Baquero V
    Parkinsonism Relat Disord; 2004 Oct; 10(7):433-7. PubMed ID: 15465402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with Parkinson's disease: development of a questionnaire.
    de Boer AG; Wijker W; Speelman JD; de Haes JC
    J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):70-4. PubMed ID: 8676165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?
    Martinez-Martin P; Serrano-Dueñas M; Forjaz MJ; Serrano MS
    Qual Life Res; 2007 Sep; 16(7):1221-30. PubMed ID: 17534735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation, Cross-Cultural Adaptation, and Validation of the Parkinson's Disease Quality of Life Questionnaire (PDQL), the "PDQL-BR", into Brazilian Portuguese.
    Campos M; de Rezende CH; Farnese Vda C; da Silva CH; Morales NM; Pinto Rde M
    ISRN Neurol; 2011; 2011():954787. PubMed ID: 22389837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and Validity of 39-Item Parkinson's Disease Questionnaire and Parkinson's Disease Quality of Life Questionnaire.
    Jesus-Ribeiro J; Vieira E; Ferreira P; Januário C; Freire A
    Acta Med Port; 2017 May; 30(5):395-401. PubMed ID: 28865504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of the Turkish version of the 39-item Parkinson Disease Questionnaire.
    Tuba BK; Elif DE; Ozgur OC; Fatos ES; Emine KAE; Ozden TO
    Ideggyogy Sz; 2023 May; 76(5-6):181-188. PubMed ID: 37294025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and Validity Study of a Turkish Version of the Sialorrhea Clinical Scale for Parkinson's Disease (SCS-TR).
    Genç G; Atalar MS
    Noro Psikiyatr Ars; 2023; 60(1):49-54. PubMed ID: 36911563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire.
    Hobson P; Holden A; Meara J
    Age Ageing; 1999 Jul; 28(4):341-6. PubMed ID: 10459785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
    Cova I; Di Battista ME; Vanacore N; Papi CP; Alampi G; Rubino A; Valente M; Meco G; Contri P; Di Pucchio A; Lacorte E; Priori A; Mariani C; Pomati S
    Parkinsonism Relat Disord; 2017 Jan; 34():38-42. PubMed ID: 28029554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and Reliability of the Turkish Version of the 8-Item Parkinson's Disease Questionnaire.
    Kahraman T; Genç A; Söke F; GÖz E; Çolakoğlu BD; Keskįnoğlu P
    Noro Psikiyatr Ars; 2018 Dec; 55(4):337-340. PubMed ID: 30622390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric characteristics of the Parkinson's disease questionnaire (PDQ-39)--Ecuadorian version.
    Martínez-Martín P; Serrano-Dueñas M; Vaca-Baquero V
    Parkinsonism Relat Disord; 2005 Aug; 11(5):297-304. PubMed ID: 15886043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.
    Sung YH; Kim HJ; Koh SB; Kim JS; Kim SJ; Cheon SM; Cho JW; Kim YJ; Ma HI; Park MY; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Kim JY; Kwon DY; Lee JH; Lee JY; Kim JS; Yun JY; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Ahn TB
    J Korean Med Sci; 2018 Jan; 33(2):e14. PubMed ID: 29215823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments.
    Marinus J; Ramaker C; van Hilten JJ; Stiggelbout AM
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):241-8. PubMed ID: 11796776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
    van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
    Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life of people with Parkinson's disease in the context of professional work and physiotherapy].
    Cholewa J; Gorzkowska A; Nawrocka A; Cholewa J
    Med Pr; 2017 Oct; 68(6):725-734. PubMed ID: 28745728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turkish version of Parkinson Fatigue Scale: Validity and reliability study of binary scoring method.
    Öztürk EA; Gönenli Koçer B; Umay E; Çakcı A
    Turk J Phys Med Rehabil; 2018 Sep; 64(3):253-260. PubMed ID: 31453519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39).
    Katsarou Z; Bostantjopoulou S; Peto V; Alevriadou A; Kiosseoglou G
    Qual Life Res; 2001; 10(2):159-63. PubMed ID: 11642686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
    Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
    J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is PDQ-39 a reliable measure of quality of life of patients at advanced stages of Parkinson's disease considered for Deep Brain Stimulation.
    Damianova M; Gancheva D; Gabrovski K; Karazapryanov P; Milenova Y; Popivanov ID; Minkin K
    Heliyon; 2024 May; 10(10):e31325. PubMed ID: 38813175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.